| Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells AM Gurney, ON Osipenko, D MacMillan, KM McFarlane, RJ Tate, ... Circulation research 93 (10), 957-964, 2003 | 238 | 2003 |
| Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors C Iehlé, S Délos, O Guirou, R Tate, JP Raynaud, PM Martin The Journal of steroid biochemistry and molecular biology 54 (5-6), 273-279, 1995 | 193 | 1995 |
| Potential role for Kv3. 1b channels as oxygen sensors ON Osipenko, RJ Tate, AM Gurney Circulation research 86 (5), 534-540, 2000 | 158 | 2000 |
| The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells C Loveridge, F Tonelli, T Leclercq, KG Lim, JS Long, E Berdyshev, ... Journal of Biological Chemistry 285 (50), 38841-38852, 2010 | 147 | 2010 |
| Trypsin stimulates proteinase-activated receptor-2-dependent and-independent activation of mitogen-activated protein kinases CM Belham, RJ Tate, PH Scott, AD Pemberton, HRP Miller, ... Biochemical journal 320 (3), 939-946, 1996 | 133 | 1996 |
| Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA S Koppu, YJ Oh, RA Edrada-Ebel, DR Blatchford, L Tetley, RJ Tate, ... Journal of Controlled Release 143 (2), 215-221, 2010 | 127 | 2010 |
| Determination of the potential bioavailability of plant microRNAs using a simulated human digestion process A Philip, VA Ferro, RJ Tate Molecular nutrition & food research 59 (10), 1962-1972, 2015 | 105 | 2015 |
| Sphingosine 1-phosphate stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle S RAKHIT, AM CONWAY, R TATE, T BOWER, NJ PYNE, S PYNE Biochemical journal 338 (3), 643-649, 1999 | 105 | 1999 |
| Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice MH Mooney, S Fogarty, C Stevenson, AM Gallagher, P Palit, SA Hawley, ... British journal of pharmacology 153 (8), 1669-1677, 2008 | 102 | 2008 |
| Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain S Somani, DR Blatchford, O Millington, ML Stevenson, C Dufès Journal of Controlled Release 188, 78-86, 2014 | 97 | 2014 |
| Lipid-based nanoparticles for cancer treatment MA Obeid, RJ Tate, AB Mullen, VA Ferro Lipid nanocarriers for drug targeting, 313-359, 2018 | 81 | 2018 |
| Exclusion of known protease activated receptors in factor VIIa-induced signal transduction LC Petersen, O Thastrup, G Hagel, BB Sørensen, PO Freskgård, ... Thrombosis and haemostasis 83 (04), 571-576, 2000 | 70 | 2000 |
| The effects of hydration media on the characteristics of non-ionic surfactant vesicles (NISV) prepared by microfluidics MA Obeid, I Khadra, AB Mullen, RJ Tate, VA Ferro International journal of pharmaceutics 516 (1-2), 52-60, 2017 | 66 | 2017 |
| Enhanced gene expression in tumors after intravenous administration of arginine-, lysine-and leucine-bearing polypropylenimine polyplex H Aldawsari, RA Edrada-Ebel, DR Blatchford, RJ Tate, L Tetley, C Dufès Biomaterials 32 (25), 5889-5899, 2011 | 65 | 2011 |
| Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells P Laskar, S Somani, SJ Campbell, M Mullin, P Keating, RJ Tate, C Irving, ... Nanoscale 11 (42), 20058-20071, 2019 | 64 | 2019 |
| Effects of CoCr metal wear debris generated from metal-on-metal hip implants and Co ions on human monocyte-like U937 cells OM Posada, RJ Tate, MH Grant Toxicology in Vitro 29 (2), 271-280, 2015 | 62 | 2015 |
| Toxicity of cobalt–chromium nanoparticles released from a resurfacing hip implant and cobalt ions on primary human lymphocytes in vitro OM Posada, RJ Tate, MH Grant Journal of Applied Toxicology 35 (6), 614-622, 2015 | 58 | 2015 |
| Tumor regression following intravenous administration of lactoferrin-and lactoferricin-bearing dendriplexes LY Lim, PY Koh, S Somani, M Al Robaian, R Karim, YL Yean, J Mitchell, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (6), 1445-1454, 2015 | 55 | 2015 |
| Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11 M Ahmad, YHA Abdel-Wahab, R Tate, PR Flatt, NJ Pyne, BL Furman British journal of pharmacology 129 (6), 1228, 2000 | 55 | 2000 |
| Formulation of nonionic surfactant vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells MA Obeid, A Elburi, LC Young, AB Mullen, RJ Tate, VA Ferro Molecular pharmaceutics 14 (7), 2450-2458, 2017 | 52 | 2017 |
